Monotherapy with mIL12 mRNA in the MC38 B2M KO tumor model, led to TGI effects in all animals in the group culminating in CRs in (7/10) and PRs in 3/10 animals (Fig. 2D and E). The gene discussed is B2M; the disease is neoplasm.